170 related articles for article (PubMed ID: 34685577)
21. Cancer stem cells and their potential implications for the treatment of solid tumors.
Grotenhuis BA; Wijnhoven BP; van Lanschot JJ
J Surg Oncol; 2012 Aug; 106(2):209-15. PubMed ID: 22371125
[TBL] [Abstract][Full Text] [Related]
22. Identification of CD90 as a marker for lung cancer stem cells in A549 and H446 cell lines.
Yan X; Luo H; Zhou X; Zhu B; Wang Y; Bian X
Oncol Rep; 2013 Dec; 30(6):2733-40. PubMed ID: 24101104
[TBL] [Abstract][Full Text] [Related]
23. BORIS up-regulates OCT4 via histone methylation to promote cancer stem cell-like properties in human liver cancer cells.
Liu Q; Chen K; Liu Z; Huang Y; Zhao R; Wei L; Yu X; He J; Liu J; Qi J; Qin Y; Li B
Cancer Lett; 2017 Sep; 403():165-174. PubMed ID: 28645561
[TBL] [Abstract][Full Text] [Related]
24. Liver cancer stem cells as a hierarchical society: yes or no?
Gu Y; Zheng X; Ji J
Acta Biochim Biophys Sin (Shanghai); 2020 Jul; 52(7):723-735. PubMed ID: 32490517
[TBL] [Abstract][Full Text] [Related]
25. Stem-like cells in human hepatoblastoma.
Fiegel HC; Glüer S; Roth B; Rischewski J; von Schweinitz D; Ure B; Lambrecht W; Kluth D
J Histochem Cytochem; 2004 Nov; 52(11):1495-501. PubMed ID: 15505344
[TBL] [Abstract][Full Text] [Related]
26. Hepatitis B virus PreS1 facilitates hepatocellular carcinoma development by promoting appearance and self-renewal of liver cancer stem cells.
Liu Z; Dai X; Wang T; Zhang C; Zhang W; Zhang W; Zhang Q; Wu K; Liu F; Liu Y; Wu J
Cancer Lett; 2017 Aug; 400():149-160. PubMed ID: 28455240
[TBL] [Abstract][Full Text] [Related]
27. Multidrug resistance and cancer stem cells in neuroblastoma and hepatoblastoma.
Alisi A; Cho WC; Locatelli F; Fruci D
Int J Mol Sci; 2013 Dec; 14(12):24706-25. PubMed ID: 24351843
[TBL] [Abstract][Full Text] [Related]
28. Surface markers of hepatocellular cancer stem cells and their clinical potential.
Feng D; Wang N; Hu J; Li W
Neoplasma; 2014; 61(5):505-13. PubMed ID: 24712843
[TBL] [Abstract][Full Text] [Related]
29. Epigenetic regulation of cancer stem cells in liver cancer: current concepts and clinical implications.
Marquardt JU; Factor VM; Thorgeirsson SS
J Hepatol; 2010 Sep; 53(3):568-77. PubMed ID: 20646772
[TBL] [Abstract][Full Text] [Related]
30. Nonsteroidal Anti-inflammatory Drugs Sensitize CD44-Overexpressing Cancer Cells to Hsp90 Inhibitor Through Autophagy Activation.
Moon HJ; Park SY; Lee SH; Kang CD; Kim SH
Oncol Res; 2019 Jul; 27(7):835-847. PubMed ID: 30982499
[TBL] [Abstract][Full Text] [Related]
31. Putative stem cells and epithelial-mesenchymal transition revealed in sections of ovarian tumor in patients with serous ovarian carcinoma using immunohistochemistry for vimentin and pluripotency-related markers.
Kenda Suster N; Smrkolj S; Virant-Klun I
J Ovarian Res; 2017 Feb; 10(1):11. PubMed ID: 28231820
[TBL] [Abstract][Full Text] [Related]
32. The expression of CD90/Thy-1 in hepatocellular carcinoma: an in vivo and in vitro study.
Sukowati CH; Anfuso B; Torre G; Francalanci P; Crocè LS; Tiribelli C
PLoS One; 2013; 8(10):e76830. PubMed ID: 24116172
[TBL] [Abstract][Full Text] [Related]
33. Identification of CD90 as Putative Cancer Stem Cell Marker and Therapeutic Target in Insulinomas.
Buishand FO; Arkesteijn GJ; Feenstra LR; Oorsprong CW; Mestemaker M; Starke A; Speel EJ; Kirpensteijn J; Mol JA
Stem Cells Dev; 2016 Jun; 25(11):826-35. PubMed ID: 27049037
[TBL] [Abstract][Full Text] [Related]
34. Stem-like cells in hepatoblastoma.
Ruck P; Xiao JC
Med Pediatr Oncol; 2002 Nov; 39(5):504-7. PubMed ID: 12228907
[TBL] [Abstract][Full Text] [Related]
35. The prognostic value of combination of CD90 and OCT4 for hepatocellular carcinoma after curative resection.
Zhao RC; Zhou J; Chen KF; Gong J; Liu J; He JY; Guan P; Li B; Qin Y
Neoplasma; 2016; 63(2):288-98. PubMed ID: 26674131
[TBL] [Abstract][Full Text] [Related]
36. Identification of cancer stem cell subpopulations of CD34(+) PLC/PRF/5 that result in three types of human liver carcinomas.
Park SC; Nguyen NT; Eun JR; Zhang Y; Jung YJ; Tschudy-Seney B; Trotsyuk A; Lam A; Ramsamooj R; Zhang Y; Theise ND; Zern MA; Duan Y
Stem Cells Dev; 2015 Apr; 24(8):1008-21. PubMed ID: 25519836
[TBL] [Abstract][Full Text] [Related]
37. CD34(+) Liver Cancer Stem Cells Were Formed by Fusion of Hepatobiliary Stem/Progenitor Cells with Hematopoietic Precursor-Derived Myeloid Intermediates.
Zeng C; Zhang Y; Park SC; Eun JR; Nguyen NT; Tschudy-Seney B; Jung YJ; Theise ND; Zern MA; Duan Y
Stem Cells Dev; 2015 Nov; 24(21):2467-78. PubMed ID: 26192559
[TBL] [Abstract][Full Text] [Related]
38. CD90 a potential cancer stem cell marker and a therapeutic target.
Shaikh MV; Kala M; Nivsarkar M
Cancer Biomark; 2016; 16(3):301-7. PubMed ID: 27062695
[TBL] [Abstract][Full Text] [Related]
39. miR-125a/b inhibits tumor-associated macrophages mediated in cancer stem cells of hepatocellular carcinoma by targeting CD90.
Wang Y; Wang B; Xiao S; Li Y; Chen Q
J Cell Biochem; 2019 Mar; 120(3):3046-3055. PubMed ID: 30536969
[TBL] [Abstract][Full Text] [Related]
40. The Notch pathway promotes the cancer stem cell characteristics of CD90+ cells in hepatocellular carcinoma.
Luo J; Wang P; Wang R; Wang J; Liu M; Xiong S; Li Y; Cheng B
Oncotarget; 2016 Feb; 7(8):9525-37. PubMed ID: 26848615
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
